| pubmed-article:6953921 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6953921 | lifeskim:mentions | umls-concept:C1522721 | lld:lifeskim |
| pubmed-article:6953921 | lifeskim:mentions | umls-concept:C0001109 | lld:lifeskim |
| pubmed-article:6953921 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:6953921 | pubmed:dateCreated | 1982-8-7 | lld:pubmed |
| pubmed-article:6953921 | pubmed:abstractText | Electrophoresis and ion-exchange column chromatography were used to separate the wide varieties of acid phosphatases with different biological and clinical significance. Band 0 was very strong in ascitic cells with many autophagic vacuoles, indicating a role in autophagic function. Band 1 was a membrane-bound acid phosphatase, seen mainly in the microsomal fraction. Band 3 was the major lysosomal acid phosphatase of all nonprostatic tissues. Bands 2 and 4 were antigenically identical to each other, and were observed in unusually high amounts in the prostate. The different electrophoretic mobility between bands 2 and 4 was due to their carbohydrate content. Band 5 was a characteristic enzyme of the osteoclast. The tartrate-sensitive enzymes included bands 0 through 4. Only band 5 was tartrate resistant. The tartrate-resistant acid phosphatase of erythrocytes was not detected by the electrophoresis method. Clinical applications were seen for both bands 2 and 5. Band 2 was a secretory enzyme, normally secreted into the seminal plasma. Band 2 was absorbed into the blood circulation in some prostatic cancer patients. A small amount of bands 2 and 4 was observed in nonprostatic tissues. The diagnostic value of band 2 resulted from its extremely high concentration in the prostate. Band 5 was not observed in the normal prostate. A high concentration of band 5 was observed in hairy cells, Gaucher cells, and osteoclasts. The serum level of band 5b was an indicator of osteoclastic activity in the bone. Elevation of band 5b in serum was observed in normal children during physiological bone growth, in Gaucher's disease, and in malignancies metastasized to bone. | lld:pubmed |
| pubmed-article:6953921 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6953921 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6953921 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6953921 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6953921 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6953921 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6953921 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6953921 | pubmed:issn | 0077-8923 | lld:pubmed |
| pubmed-article:6953921 | pubmed:author | pubmed-author:YamL TLT | lld:pubmed |
| pubmed-article:6953921 | pubmed:author | pubmed-author:LamK WKW | lld:pubmed |
| pubmed-article:6953921 | pubmed:author | pubmed-author:LiC YCY | lld:pubmed |
| pubmed-article:6953921 | pubmed:author | pubmed-author:SmithR SRS | lld:pubmed |
| pubmed-article:6953921 | pubmed:author | pubmed-author:HackerBB | lld:pubmed |
| pubmed-article:6953921 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6953921 | pubmed:volume | 390 | lld:pubmed |
| pubmed-article:6953921 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6953921 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6953921 | pubmed:pagination | 1-15 | lld:pubmed |
| pubmed-article:6953921 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:meshHeading | pubmed-meshheading:6953921-... | lld:pubmed |
| pubmed-article:6953921 | pubmed:year | 1982 | lld:pubmed |
| pubmed-article:6953921 | pubmed:articleTitle | Comparison of prostatic and nonprostatic acid phosphatase. | lld:pubmed |
| pubmed-article:6953921 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6953921 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:6953921 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6953921 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6953921 | lld:pubmed |
